Screener
Ligand Pharmaceuticals LGND Contract revenue and income — Total revenues and income
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
| Line item | Three months ended / June 30, 2026 | Three months ended / June 30, 2025 | Six months ended / June 30, 2026 | Six months ended / June 30, 2025 |
|---|---|---|---|---|
| Income from financial royalty assets | 10,670 | 6,313 | 20,697 | 12,215 |
| Royalties | 48,032 | 36,397 | 90,990 | 63,886 |
| Captisol | 7,978 | 8,287 | 16,632 | 21,747 |
| Contract revenue and income | 7,683 | 2,943 | 7,793 | 7,327 |
| Total revenues and income | 63,693 | 47,627 | 115,415 | 92,960 |
| Operating costs and expenses: | ||||
| Cost of Captisol | 3,214 | 2,907 | 6,487 | 7,756 |
| Amortization of intangibles | 8,097 | 8,258 | 16,194 | 16,515 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Ligand Pharmaceuticals's contract revenue and income — total revenues and income?
- Ligand Pharmaceuticals (LGND) reported contract revenue and income — total revenues and income of $7.68M in Q2 2026.
- How has Ligand Pharmaceuticals's contract revenue and income — total revenues and income changed year-over-year?
- Ligand Pharmaceuticals's contract revenue and income — total revenues and income increased by 161.1% year-over-year, from $2.94M to $7.68M.
- What does contract revenue and income — total revenues and income mean?
- This metric represents the aggregate financial inflows generated from contract-based arrangements, including license fees, milestone payments, and service-related income within a specific business segment. It reflects the company's ability to monetize its intellectual property and development expertise through strategic partnerships with third-party pharmaceutical and biotechnology entities. This revenue stream is a key indicator of the commercial success and adoption of the company's underlying technology platforms.
Ask your AI about Ligand Pharmaceuticals's contract revenue and income — total revenues and income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude